Flunixin Meglumine for Veterinary Use
by Barbara Forney, VMD
Nonsteroidal anti-inflammatory drug (NSAID)
May Be Prescribed by Vets for:
Pain relief, anti-inflammatory, antipyretic, endotoxemia protection.
Flunixin Meglumine is
commercially available as an Injectable 50mg/ml. and
oral paste 1,500mg.
Search for Available Dosage Forms
Flunixin meglumine is a nonsteroidal anti-inflammatory drug (NSAID) and cyclooxygenase inhibitor. It is a potent analgesic, antipyretic, and anti-inflammatory. NSAIDs work by inhibiting the body's production of prostaglandins and other chemicals that stimulate the body's inflammatory response. Some of these actions may be dose-dependent. NSAIDs are quickly absorbed into the blood stream; pain relief and fever reduction usually starts within one to two hours.
Flunixin meglumine commonly is used for pain relief to treat colic. It is used for protection from septic/endotoxic shock due to any gastrointestinal (GI) insult either post surgical or medical such as in cases of peritonitis or diarrhea. Flunixin is used commonly as an anti-inflammatory to treat painful conditions of the eye including corneal ulcers, uveitis, conjunctivitis, and before and after eye surgery. It may be used to reduce or control fevers due to viral or bacterial infections. Although flunixin can be used to treat arthritis, there are other NSAIDs that are prescribed more commonly for this purpose.
Flunixin may be given IV, IM or orally.
Flunixin Meglumine Side Effects
- The most-common side effects include GI ulceration, especially of the stomach and large colon.
- Rare side-effects include kidney damage and bleeding disorders.
- Allergic reactions are rare but have been reported.
- GI side-effects such as ulcers are more likely to occur with prolonged oral dosing. Renal problems are more likely to occur in the dehydrated or debilitated horse. NSAIDS should be avoided or very carefully monitored in horses with liver disease, kidney disease, or those prone to GI ulcers.
- Side effects from NSAID use are more common with phenylbutazone than with flunixin.
- Flunixin should be used with caution in the pregnant or nursing mare. No adverse effect on sperm production has been reported.
- Flunixin is used in foals, but it should be used with particular caution to avoid GI ulceration and maintain kidney function. Premature foals, septicemic foals, foals with questionable kidney or liver function, and foals with diarrhea require careful monitoring. Drugs to protect the GI tract such as omeprazole, cimetidine, or sucralfate are frequently used with flunixin.
- Pony breeds may be more susceptible to side effects from NSAIDs than horses. When flunixin is used in ponies, it should be used with caution and at the lowest effective dose.
- Older horses and especially those with decreased kidney or liver function may be more at risk for side effects. When flunixin is used in older horses it should be used carefully and at the lowest effective dose.
- Injectable flunixin can be given IM, but injection site reactions, including localized pain, swelling, muscle inflammation or damage sometimes occur.
- Some veterinarians and many horse owners, particularly those involved in showing, use more than one NSAID in combination, for example, flunixin and phenylbutazone given together. Although there is little experimental evidence to support this practice, the theory is that different NSAIDs may act differently on different body systems. Particular care needs to be taken in this situation to avoid additive toxicity.
- Avoid combining with other anti-inflammatory drugs that tend to cause GI ulcers, such as corticosteroids and other NSAIDs.
- Use with caution with aminoglycoside antibiotics such as gentamicin and amikacin and oral anticoagulants such as warfarin and other coumarin derivatives.
- A single miscalculated dose is not likely to produce toxicity. Experimentally it has taken three to five times the normal dose over multiple days to produce toxicity.
- Overdose with flunixin will increase the likelihood and severity of the mentioned side effects. Early signs of toxicity include loss of appetite and depression.
About the Author
Dr. Barbara Forney is a veterinary practitioner in Chester County, Pennsylvania. She has a master's degree in animal science from the University of Delaware and graduated from the University of Pennsylvania School of Veterinary Medicine in 1982.
She began to develop her interest in client education and medical writing in 1997. Recent publications include portions of The Pill Book Guide to Medication for Your Dog and Cat, and most recently Understanding Equine Medications published by the Bloodhorse.
Dr. Forney is an FEI veterinarian and an active member of the AAEP, AVMA, and AMWA.
The information contained on this site is general in nature and is intended for use as an informational aid. It does not cover all possible uses, actions, precautions, side effects, or interactions of the products shown, nor is the information intended as medical advice or diagnosis for individual health problems or for making an evaluation as to the risks and benefits of using a particular product. You should consult your doctor about diagnosis and treatment of any health problems. Information and statements have not been evaluated by the Food and Drug Administration ("FDA"), nor has the FDA approved the products to diagnose, cure or prevent disease.
Wedgewood Pharmacy compounded veterinary preparations are not intended for use in food and food-producing animals.